Nuveen’s Cavium, Inc. CAVM Stock Holding History

Nuveen’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,241	Closed	-$232K	–	1431
2017 Q1	$232K	Sell	3,241 -1,310	-29%	-$87.7K	﹤0.01%	1300
2016 Q4	$284K	Buy	+4,551	New	+$263K	﹤0.01%	1415
2016 Q2	–	Sell	-20,357	Closed	-$1.25K	–	1481
2016 Q1	$1.25K	Buy	20,357 +16,424	+418%	+$948K	0.01%	941
2015 Q4	$258	Sell	3,933 -165	-4%	-$11.1K	﹤0.01%	1403
2015 Q3	$251	Sell	4,098 -17,796	-81%	-$1.19M	﹤0.01%	1453
2015 Q2	$1.51K	Sell	21,894 -2,000	-8%	-$140K	0.01%	962
2015 Q1	$1.69M	Buy	23,894 +1,307	+6%	+$84.8K	0.01%	924
2014 Q4	$1.4M	Buy	22,587 +18,243	+420%	+$965K	0.01%	1032
2014 Q3	$216K	Sell	4,344 -119,298	-96%	-$6.04M	﹤0.01%	1499
2014 Q2	$6.14M	Buy	123,642 +88,737	+254%	+$4.08M	0.04%	507
2014 Q1	$1.53M	Buy	+34,905	New	+$1.37M	0.01%	928

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen's CAVM Position: Q2 2017 in Review

Nuveen sold out of Cavium, Inc. (CAVM) in Q2 2017, closing a stake of 3,241 shares — an estimated $232K sold.

Nuveen first reported a position in CAVM in Q1 2014 and held it in 11 quarters. The position peaked at $6.14M in Q2 2014. 250 funds tracked by Wall St. Rank hold CAVM as of Q2 2017.

Nuveen reported no remaining Cavium, Inc. position as of Q2 2017 after selling out during the quarter.
Nuveen sold 3,241 Cavium, Inc. shares in Q2 2017, an estimated $232K.
Nuveen first reported a position in Cavium, Inc. in Q1 2014 and held it in 11 quarters.
Nuveen's Cavium, Inc. position peaked at $6.14M in Q2 2014.
250 funds tracked by Wall St. Rank held Cavium, Inc. as of Q2 2017.

Based on Nuveen's 13F filing for Q2 2017, filed 14 Aug 2017.